LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 92.25 | 27.76 | 12211 | 6873 | 1.7766 | 1.1499 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 93.96 | 27.76 | 1 | 6849 | 0.0001 | -0.3418 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 93.96 | 27.76 | 4265 | 6849 | 0.6227 | 0.8843 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 93.96 | 27.76 | 3436 | 6849 | 0.5017 | 0.8337 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 93.96 | 27.76 | 12426 | 6849 | 1.8143 | 1.1557 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 95.66 | 27.76 | 1 | 6712 | 0.0001 | -0.3428 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 95.66 | 27.76 | 1737 | 6712 | 0.2588 | 0.6861 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 95.66 | 27.76 | 3298 | 6712 | 0.4913 | 0.8283 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 95.66 | 27.76 | 12727 | 6712 | 1.8960 | 1.1683 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 1.95 | 27.76 | 597 | 225 | 2.6516 | 1.7623 | MN20160318_Q01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 1.95 | 27.76 | 8 | 225 | 0.0355 | -0.3377 | MN20160318_Q01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 1.95 | 27.76 | 616 | 225 | 2.7360 | 1.7911 | MN20160318_Q01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 3.66 | 27.76 | 655 | 283 | 2.3069 | 1.5660 | MN20160318_Q01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 3.66 | 27.76 | 9 | 283 | 0.0317 | -0.2852 | MN20160318_Q01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 3.66 | 27.76 | 681 | 283 | 2.3985 | 1.5959 | MN20160318_Q01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 5.36 | 27.76 | 747 | 320 | 2.3318 | 1.5423 | MN20160318_Q01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 5.36 | 27.76 | 12 | 320 | 0.0375 | -0.2115 | MN20160318_Q01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 5.36 | 27.76 | 792 | 320 | 2.4722 | 1.5848 | MN20160318_Q01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 7.06 | 27.76 | 852 | 360 | 2.3667 | 1.5248 | MN20160318_Q01 | K03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 7.06 | 27.76 | 8 | 360 | 0.0222 | -0.2858 | MN20160318_Q01 | N03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 7.06 | 27.76 | 891 | 360 | 2.4750 | 1.5556 | MN20160318_Q01 | N03 |